앨라배마의 폐암 임상 시험
폐암 관련 연구 15개가 앨라배마 내 여러 지역에서 참여자를 모집하고 있습니다.
앨라배마의 도시
공식 연구 텍스트(영어)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology, Birmingham
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06712316A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- University of Alabama at Birmingham, Birmingham
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07154290Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Alabama Birmingham, Birmingham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- 외 1개
피험자 모집 중2상
18 Minutes · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06616584Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07489066A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06343402Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05624996Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572MYLUNG Consortium Part 3: Observational Study
- Southern Cancer Center, PC, Daphne
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT05885698Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 30. 업데이트됨 · NCT05297734SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 10. 24. 업데이트됨 · NCT06228326ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.